Effect of clinical trial eligibility criteria on patient selection for advanced biliary tract cancers

被引：0
|
作者：
Walmsley, C. S. [1 ]
Ellis, H. [2 ]
Baiev, I. [3 ]
Reyes, S. [3 ]
Goyal, L. [4 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Internal Med, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Oncol, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Oncol, Boston, MA 02114 USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320P
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [1] Comparison of Clinical Trial Results of the Recently Approved Immunotherapeutic Drugs for Advanced Biliary Tract Cancers
    Das, Samayita
    REVIEWS ON RECENT CLINICAL TRIALS, 2024, 19 (02) : 81 - 90
  • [2] Gemcitabine in advanced biliary tract cancers
    Pasetto, Lara Maria
    Andrea, Mario Rosario D'
    Falci, Cristina
    Monfardini, Silvio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 230 - 242
  • [3] Immunotherapy in Advanced Biliary Tract Cancers
    Boileve, Alice
    Hilmi, Marc
    Smolenschi, Cristina
    Ducreux, Michel
    Hollebecque, Antoine
    Malka, David
    CANCERS, 2021, 13 (07)
  • [4] FOLFIRI in advanced biliary tract cancers.
    Mizrahi, Jonathan
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phani Keerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Nanoliposomal irinotecan in advanced biliary tract cancers
    Malka, David
    Colle, Raphael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (08): : 683 - 684
  • [6] Gemcitabine treatment for advanced biliary tract cancers
    Fujita, Tsunenori
    Ajiki, Tetsuo
    Matsumoto, Ippei
    Hirata, Kenro
    Takase, Shiro
    Kamigaki, Takashi
    Shinzeki, Makoto
    Fujino, Yasuhiro
    Kuroda, Yeshikazu
    Ku, Yonson
    GASTROENTEROLOGY, 2007, 132 (04) : A202 - A202
  • [7] mTOR Inhibitors in Advanced Biliary Tract Cancers
    Wu, Chao-En
    Chen, Ming-Huang
    Yeh, Chun-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [8] Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed O.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal P. S.
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    JAMA ONCOLOGY, 2019, 5 (06) : 824 - 830
  • [9] Continuum of care for advanced biliary tract cancers
    Vienot, Angelique
    Neuzillet, Cindy
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 810 - 824
  • [10] AI uses patient data to optimize selection of eligibility criteria for clinical trials
    Chunhua Weng
    James R. Rogers
    Nature, 2021, 592 (7855) : 512 - 513
12345